The molecular pathogenesis of obesity: An unfinished jigsaw puzzle

Annals of the Academy of Medicine Singapore

Volumn 29, Issue 3, 2000, Pages 388-395

  Lee, Y S ^a   Loke, K Y ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NONE

Author keywords

Agouti related protein; Leptin; Melanocortin 4 receptor; Neuropeptide Y; Uncoupling protein

Indexed keywords

LEPTIN; MELANOCORTIN 4 RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PEROXISOME-PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA COACTIVATOR-1; RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL; BODY MASS; DISEASE MODEL; ENERGY METABOLISM; GENETIC LINKAGE; GENETICS; HOMEOSTASIS; HUMAN; OBESITY; PHENOTYPE; PHYSIOLOGY; REVIEW; SATIETY;

ANIMALS; BODY MASS INDEX; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; LEPTIN; LINKAGE (GENETICS); OBESITY; PHENOTYPE; RECEPTOR, MELANOCORTIN, TYPE 4; RECEPTORS, PEPTIDE; SATIATION; TRANSCRIPTION FACTORS;

EID: 0034186432     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. National Health Survey 1998. Singapore: Epidemiology & Disease Control Department, Public Health Division, Ministry of Health, 1998: 23-32.
2. Rajan U. Annual Report, 1995-1996. School Health Services.
3. Stark O, Atkins E, Wolff O H, Douglas J W. Longitudinal study of obesity in the national Survey of Health and Development. BMJ 1981; 281:273-84.
4. Rosenbaum M, Rudolph L, Hirsch L J. Obesity. N Engl J Med 1997; 337:396-407.
5. Frisch R E, McArthur J W. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974; 185:949-51.
6. Neel J V. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet 1962; 14:353-62.
7. Bouchard C, editor. Genetics of obesity. Boca Raton, Fla.: CRC Press, 1994.
8. Rosenbaum M, Leibel R L. Pathophysiology of childhood obesity. Adv Pediatr 1988; 35:73-137.
9. Choi S J, Dallman M F. Hypothalamic obesity: Multiple routes mediated by loss of function in medial cell groups. Endocrinology 1999; 140:4081-8.
10. Hervey G R. Regulation of energy balance. Nature 1969; 372:406-7.
11. Harris R B S, Martin R J. Specific depletion of body fat in parabiotic partners of tube-fed obese rats. Am J Physiol 1984; 247:R380-6.
12. Coleman D L. Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 1973; 9:294-8.
13. Leibel R L, Chung W K, Chua S C Jr. The molecular genetics of rodent single gene obesities. J Biol Chem 1997; 272:31937-40.
14. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-32.
15. Tartaglia L A, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 1993; 83:1263-71.
16. Haiaas J L, Gajiwala K S, Maffei M, Cohen S L, Chait B T, Rabinowitz D, et al. Weight-reducing effect of the plasma protein encoded by the obese gene. Science 1995; 269:542-6.
17. Levin N, Nelson C, Gurney A, Vandlen R, de Sauvage F. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proc Natl Acad Sci U S A 1996; 93:1726-30.
18. Weigle D S, Bukowski T R, Foster D C, Holderman S, Kramer J M, Lasser G, et al. Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest 1995; 96:2065-70.
19. Schwanz M W, Baskin D G, Bukowski T R, Kuijper J L, Foster D, Lasser G, et al. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 1996; 45:531-5.
20. Halaas J L, Gajiwala K S, Maffei M, Cohen S L, Chait B T, Rabinowitz D, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543-6.
21. Pelleymounter M A, Cullen M, Baker M J, Hecht R, Winters D, Boone T, et al. Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540-3.
22. Campfield L A, Smith F J, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269:546-9.
23. Collins S, Kuhn C M, Petro A E, Swick A G, Chrunyk B A, Surwit R S. Role of leptin in fat regulation. Nature 1996; 380:677.
24. Campfield L A, Smith F J, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269:546-9.
25. Greenberg A, Heymsfield S, Fujioka K, Dixon R M, Kushner R, Hunt T, et al. Preliminary safety and efficacy of recombinant methionyl human leptin administered by sc injection in lean and obese subjects [abstract]. Presented at the 58th Scientific Sessions of the American Diabetes Association; 1998 June 13-16; Chicago. Chicago: American Diabetes Association, 1998.
26. Rosenbaum M, Leibel R L. The role of leptin in human physiology. N Engl J Med 1999; 341:913-5.
27. Friedman J M, Leibel R L, Siegel D S, Walsh J, Bahary N. Molecular mapping of the mouse ob mutation. Genomics 1991; 11:1054-62.
28. Geffroy S, De Vos P, Staels B, Duban B, Auwerx J, de Martinville B. Localization of the human OB gene (OBS) to chromosome 7q32 by fluorescence in situ hybridization. Genomics 1995; 28:603-4.
29. Montague C T, Farooqi I S, Whitehead J P, Soos M A, Rau H, Wareham N J, et al. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387:903-8.
30. Rau H, Reaves B J, O'rahilly S, Whitehead J P. Truncated human leptin (D133) associated with extreme obesity undergoes proteasomal degradation after defective intracellular transport. Endocrinology 1999; 140:1718-23.
31. Farooqi I S, Jebb S A, Langmack G, Lawrence E, Cheetham C H, Prentice A M, et al. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341:879-84.
32. Strobel A, Issad T, Camoin L, Ozata M, Strosberg A D. A leptin missense mutation associated with hypogonadism and morbid obesity [letter]. Nat Genet 1998; 18:213-5.
33. Considine R V, Sinha M K, Heiman M L, Kriauciunas A, Stephens T W, Nyce M R, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:292-5.
34. Clement K, Garner C, Hager J, Philippi A, Le Duc C, Carey A, et al. Indication for linkage of the human OB gene region with extreme obesity. Diabetes 1996; 45:687-90.
35. Reed D R, Ding Y, Xu W, Cather C, Green E D, Price R A. Extreme obesity may be linked to markers flanking the human OB gene. Diabetes 1996; 45:691-4.
36. Duggirala R, Stern M P, Mitchell B D, Reinhart L J, Shipman P A, Uresandi O C, et al. Quantitative variation in obesity-related traits and insulin precursors linked to the OB gene region on human chromosome 7. Am J Hum Genet 1996; 59:694-703.
37. Considine R V, Considine E L, Williams C J, Nyce M R, Magosin S A, Bauer T L, et al. Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest 1995; 95:2986-8.
38. Considine R V, Considine E L, Williams C J, Nyce M R, Zhang P, Opentanova I, et al. Mutation screening and identification of a sequence variation in the human ob gene coding region. Biochem Biophys Res Commun 1996; 220:735-9.
39. Lee G H, Proenca R, Montez J M, Carroll K M, Darvishzadeh J G, Lee J I, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379:632-5.
40. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield S B, Gallagher D, Chu F, et al. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab 1996; 81:3424-7.
41. Considine R V, Considine E L, Williams C J, Hyde T M, Caro J F. The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations. Diabetes 1996; 19:992-4.
42. Gotoda T, Manning B S, Goldstone A P, Imrie H, Evans A L, Strosberg A D, et al. Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet 1997; 6:869-76.
43. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, et al. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998; 392:398-401.
44. Zukowska-Grojec Z, Neuropeptide Y: anovel sympathetic stress hormone and more. Ann NY Acad Sci 1995; 771:219-33.
45. Schwanz M W, Figlewicz D P, Woods S C, Porte D Jr, Baskin D G. Insulin, neuropeptide Y, and food intake. Ann NY Acad Sci 1993; 692:60-71.
46. Chua S C Jr, Brown A W, Kim J, Hennessey K L, Leibel R L, Hirsch J. Food deprivation and hypothalamic neuropeptide gene expression: effects of strain background and the diabetes mutation. Brain Res Mol Brain Res 1991; 11:291-9.
47. Billington C J, Briggs J E, Harker S, Grace M, Levine A S. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 1994; 266:R1765-70.
48. Erickson J C, Clegg K E, Palmiter R D. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y. Nature 1996; 381:415-21.
49. Karvonen M K, Pesonen U, Koulu M, Niskanen L, Laakso M, Rissanen A, et al. Association of a Ieucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat Med 1998; 4:1434-7.
50. Uusitupa M I J, Karvonen M K, Pesonen U, Koulu M. Neuropeptide Y: a novel link between the neuroendocrine system and cholesterol metabolism. Ann Med 1998; 30:508-10.
51. Mountjoy K G, Mortrud M T, Low M J, Simerly R B, Cone R D. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994; 8:1298-308.
52. Mountjoy K G, Wild J M. Melanocortin-4 receptor mRNA expression in the developing autonomie and central nervous systems. Brain Res Dev Brain Res 1998; 107:309-14.
53. Sundaramurthy D, Campbell D A, Leek J P, Markham A F, Pieri L F. Assignment of the melanocortin 4 receptor (MC4R) gene to human chromosome band 18q22 by in situ hybridisation and radiation hybrid mapping. Cytogenet Cell Genet 1998; 82:97-8.
54. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson S J, et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 1993; 268:15174-9.
55. Huszar D, Lynch C A, Fairchild-Huntress V, Dunmore J H, Fang Q, Berkemeier L R, et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997; 88:131-41.
56. Kawai Y, Inagaki S, Shiosaka S, Shibasaki T, Ling N, Tohyama M, et al. The distribution and projection of γ-melanocyte stimulating hormone in the rat brain: an immunohistochemical analysis. Brain Res 1984; 297:21-32.
57. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A. Severe early-onset obesity, adrenal insufficiency and red hair pigmentataion caused by POMC mutations in humans. Nat Genet 1998; 19:155-7.
58. fat mice. Cell 1997; 88:73-83.
59. Jackson R S, Creemers J W M, Ohagi S, et al. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 1997; 16:303-6.
60. Jackson R S, O'Rahilly S, Brain C, Nussey S S. Proopiomelanocortin products and human early-onset obesity [letter]. J Clin Endocrinol Metab 1999; 84:819.
61. Vaisse C, Clement K, Guy-Grand B, Froguel P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat Genet 1998; 20:113-4.
62. Yeo G S, Farooqi I S, Aminian S, Halsall D J, Stanhope R G, O'Rahilly S. A frameshift mutation in MC4-R associated with dominantly inherited human obesity. Nat Genet 1998; 20:111-2.
63. Hinney A, Schmidt A, Nottebom K, Heibült O, Becker I, Ziegler A, et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J Clin Endocrinol Metab 1999; 84:1483-6.
64. Michaud E J, Mynatt R L, Miltenverger R J, Klebig M L, Wilkinson J E, Zemel M B, et al. Role of the agouti gene in obesity. J Endocrinol 1997; 155:207-9.
65. Graham M, Shutter J R, Sarmiento U, Sarosi I, Stark K L. Overexpression of Agrt leads to obesity in transgenic mice. Nature Genet 1997; 17:273-4.
66. Fan W, Boston B A, Kesterson R A, Ilruby V J, Cone R D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997; 385:165-8.
67. Shutter J R, Graham M, Kinsey A C, Scully S, Luthy R, Stark K L. Hypothalamic expression of ART, a novel gene related to agouti, is upregulated in obese and diabetic mutant mice. Genes Dev 1997; 11:593-602.
68. Ollmann M M, Wilson B D, Yang Y K, Kerns J A, Chen Y, Gantz I, et al. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278:135-8.
69. Spiegelman B M, Flier J S. Adipogenesis: rounding out the big picture. Cell 1996; 87:377-89.
70. Latruffe N, Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochemie 1997; 79:81-94.
71. Greene M E, Blumberg B, McBride O W, Yi H F, Kronquist K, Kwan K, et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 1995; 4:281-99.
72. Beamer B A, Negri C, Yen C J, Gavrilova O, Rumberger J M, Durcan M J, et al. Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR-gamma) gene. Biochem Biophys Res Commun 1997; 233:756-9.
73. Tontonoz P, Hu E, Spiegelman B M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell 1994; 79:1147-56.
74. Hu E, Kim J B, Sarraf P, Spiegelman B M. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR gamma. Science 1996; 274:2100-3.
75. Ristow M, Müller-Wieland D, Pfeiffer A, Krone W, Kahn C R. Obesity associated with a mutation in the genetic regulator of adipocyte differentiation. N Engl J Med 1998; 339:953-9.
76. Bray M S, Boerwinkle E, Hanis C L. Linkage analysis of candidate obesity genes among the Mexican-American population of Starr County, Texas. Genet Epidemiol 1999; 16:397-411.
77. Norman R A, Tataranni P A, Pratley R, Thompson D B, Hanson R L, Prochazka M, et al. Autosomal genomic scan for loci linked to obesity and energy metabolism in Pima Indians. Am J Hum Genet 1998; 62:659-68.